| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |